HSHHSH Health Technology Supplier Hub
Home › Suppliers › Intuitive Surgical › Risk

Intuitive Surgical: risk summary

Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.

Financial

Latest full-year results from official filings.

FY2025 revenue $10.06bn (+20.5%); operating margin 29.3%; net income $2.86bn.

No debt; $9.03bn cash and investments.

Researched 8 Nov 2026

Adverse media

Credible news about incidents, disputes, legal action or restructuring in the last 24 months.

Aug 2026: The US Ninth Circuit revived an antitrust claim by Surgical Instrument Service Co. alleging Intuitive unlawfully controlled the aftermarket for da Vinci instruments, reversing a lower court ruling; the claims remain unproven.

Researched 10 Nov 2026

Cyber & information governance

Data breaches, cyber incidents, regulator action and assurance status.

Mar 2026: Intuitive disclosed a targeted phishing attack that exposed customer contact, employee and corporate data from internal business applications; it said da Vinci, Ion and digital platforms were not affected and the incident was contained. NHS DSPT status not yet checked.

Researched 10 Nov 2026

Regulatory & clinical safety

Recalls, safety notices, regulator action and clinical safety concerns.

Dec 2025: Intuitive began a Class 2 recall of da Vinci S/Si Permanent Cautery Hook instruments after more complaints of frayed or broken pitch cables; FDA attributed the cause to process change control.

Researched 10 Nov 2026

Contract performance

Contract delivery, go-lives, terminations and disputes.

No notable contract disputes, terminations or significant NHS/UK public sector contracts involving Intuitive Surgical found in HSH's search of the last 24 months.

Researched 10 Nov 2026